Search research articles
Contact Us
Filters
Showing results (111-120 of 131) with videos related to
Page
of 14
Sort By:
Medrxiv : the Preprint Server for Health Sciences
|
September 25, 2023
A clinicogenomic model including GARD predicts outcome for radiation treated patients with HPV+ oropharyngeal squamous cell carcinoma
Emily Ho, Loris De Cecco, Stefano Cavalieri, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 29, 2025
Longitudinal assessment of plasma EBV-DNA in non-endemic EBV-related nasopharyngeal cancer (NPC): the LEA study
Salvatore Alfieri, Rebecca Romanò, Sara Marceglia, et al.
Thyroid : Official Journal of the American Thyroid Association
|
June 24, 2026
Targeted Therapy-Induced Erythrocytosis in Thyroid Cancers: An Underrecognized Safety Signal from a Retrospective Study
Silvia Marchesi, Rebecca Romanò, Andrea Spagnoletti, et al.
JCO Precision Oncology
|
November 5, 2021
Clinical Validity of a Prognostic Gene Expression Cluster-Based Model in Human Papillomavirus-Positive Oropharyngeal Carcinoma
Stefano Cavalieri, Mara S Serafini, Andrea Carenzo, et al.
The Oncologist
|
December 21, 2023
Hedgehog Inhibitors Beyond Clinical Complete Response in Basal Cell Carcinoma: Should I Stop or Should I Go?
Salvatore Alfieri, Rebecca Romanò, Sara Marceglia, et al.
Frontiers in Oncology
|
February 17, 2023
A multicenter randomized trial for quality of life evaluation by non-invasive intelligent tools during post-curative treatment follow-up for head and neck cancer: Clinical study protocol
Stefano Cavalieri, Claudia Vener, Marissa LeBlanc, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
November 19, 2020
AKR1C3 is a biomarker and druggable target for oropharyngeal tumors
Caterina Peraldo-Neia, Paola Ostano, Maurizia Mello-Grand, et al.
Plos One
|
May 23, 2020
Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy
Simon Keek, Sebastian Sanduleanu, Frederik Wesseling, et al.
Cells
|
October 14, 2022
An Inflammatory Signature to Predict the Clinical Benefit of First-Line Cetuximab Plus Platinum-Based Chemotherapy in Recurrent/Metastatic Head and Neck Cancer
Stefano Cavalieri, Mara Serena Serafini, Andrea Carenzo, et al.
Frontiers in Oncology
|
October 2, 2023
Head and neck cancers survival in Europe, Taiwan, and Japan: results from RARECAREnet Asia based on a privacy-preserving federated infrastructure
Laura Botta, Tomohiro Matsuda, Hadrien Charvat, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 131) with videos related to
Sort By:
Page
of 14
Medrxiv : the Preprint Server for Health Sciences
|
September 25, 2023
A clinicogenomic model including GARD predicts outcome for radiation treated patients with HPV+ oropharyngeal squamous cell carcinoma
Emily Ho, Loris De Cecco, Stefano Cavalieri, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 29, 2025
Longitudinal assessment of plasma EBV-DNA in non-endemic EBV-related nasopharyngeal cancer (NPC): the LEA study
Salvatore Alfieri, Rebecca Romanò, Sara Marceglia, et al.
Thyroid : Official Journal of the American Thyroid Association
|
June 24, 2026
Targeted Therapy-Induced Erythrocytosis in Thyroid Cancers: An Underrecognized Safety Signal from a Retrospective Study
Silvia Marchesi, Rebecca Romanò, Andrea Spagnoletti, et al.
JCO Precision Oncology
|
November 5, 2021
Clinical Validity of a Prognostic Gene Expression Cluster-Based Model in Human Papillomavirus-Positive Oropharyngeal Carcinoma
Stefano Cavalieri, Mara S Serafini, Andrea Carenzo, et al.
The Oncologist
|
December 21, 2023
Hedgehog Inhibitors Beyond Clinical Complete Response in Basal Cell Carcinoma: Should I Stop or Should I Go?
Salvatore Alfieri, Rebecca Romanò, Sara Marceglia, et al.
Frontiers in Oncology
|
February 17, 2023
A multicenter randomized trial for quality of life evaluation by non-invasive intelligent tools during post-curative treatment follow-up for head and neck cancer: Clinical study protocol
Stefano Cavalieri, Claudia Vener, Marissa LeBlanc, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
November 19, 2020
AKR1C3 is a biomarker and druggable target for oropharyngeal tumors
Caterina Peraldo-Neia, Paola Ostano, Maurizia Mello-Grand, et al.
Plos One
|
May 23, 2020
Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy
Simon Keek, Sebastian Sanduleanu, Frederik Wesseling, et al.
Cells
|
October 14, 2022
An Inflammatory Signature to Predict the Clinical Benefit of First-Line Cetuximab Plus Platinum-Based Chemotherapy in Recurrent/Metastatic Head and Neck Cancer
Stefano Cavalieri, Mara Serena Serafini, Andrea Carenzo, et al.
Frontiers in Oncology
|
October 2, 2023
Head and neck cancers survival in Europe, Taiwan, and Japan: results from RARECAREnet Asia based on a privacy-preserving federated infrastructure
Laura Botta, Tomohiro Matsuda, Hadrien Charvat, et al.
Page
of 14